# O-I Glass, Inc.: financial statements, quarterly OI · NYSE · CIK 812074 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/oi.md) · [Financials](/companies/oi/financials.md) · [Filings](/companies/oi/filings.md) · [Insiders](/companies/oi/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/oi/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [1,743](/filings/0001558370-24-013964.md) | [1,641 d](/filings/0001104659-26-014319.md) | [1,593](/filings/0001558370-25-006008.md) | [1,729](/filings/0001558370-25-009803.md) | [1,679](/filings/0001104659-25-107047.md) | [1,529 d](/filings/0001104659-26-014319.md) | [1,567](/filings/0001104659-26-051576.md) | [1,706](/filings/0001104659-26-088166.md) | [1,653](/filings/0001104659-25-107047.md) | [1,500 d](/filings/0001104659-26-014319.md) | [1,540](/filings/0001104659-26-051576.md) | [1,668](/filings/0001104659-26-088166.md) | | Cost of revenue | $m | [1,379](/filings/0001558370-24-013964.md) | [1,410 d](/filings/0001104659-26-014319.md) | [1,275](/filings/0001558370-25-006008.md) | [1,426](/filings/0001558370-25-009803.md) | [1,464](/filings/0001104659-25-107047.md) | [1,321 d](/filings/0001104659-26-014319.md) | [1,287](/filings/0001104659-26-051576.md) | [1,407](/filings/0001104659-26-088166.md) | [1,353](/filings/0001104659-25-107047.md) | [1,270 d](/filings/0001104659-26-014319.md) | [1,341](/filings/0001104659-26-051576.md) | [1,454](/filings/0001104659-26-088166.md) | | Gross profit | $m | [364](/filings/0001558370-24-013964.md) | [231 d](/filings/0001104659-26-014319.md) | [318](/filings/0001558370-25-006008.md) | [303](/filings/0001558370-25-009803.md) | [215](/filings/0001104659-25-107047.md) | [208 d](/filings/0001104659-26-014319.md) | [280](/filings/0001104659-26-051576.md) | [299](/filings/0001104659-26-088166.md) | [300](/filings/0001104659-25-107047.md) | [230 d](/filings/0001104659-26-014319.md) | [199](/filings/0001104659-26-051576.md) | [214](/filings/0001104659-26-088166.md) | | Research and development | $m | [24.0](/filings/0001558370-24-013964.md) | [26.0 d](/filings/0001104659-26-014319.md) | [21.0](/filings/0001558370-25-006008.md) | [20.0](/filings/0001558370-25-009803.md) | [20.0](/filings/0001104659-25-107047.md) | [18.0 d](/filings/0001104659-26-014319.md) | [13.0](/filings/0001104659-26-051576.md) | [11.0](/filings/0001104659-26-088166.md) | [8.0](/filings/0001104659-25-107047.md) | [9.0 d](/filings/0001104659-26-014319.md) | [9.0](/filings/0001104659-26-051576.md) | [9.0](/filings/0001104659-26-088166.md) | | Selling, general and administrative | $m | [134](/filings/0001558370-24-013964.md) | [116 d](/filings/0001104659-26-014319.md) | [123](/filings/0001558370-25-006008.md) | [110](/filings/0001558370-25-009803.md) | [103](/filings/0001104659-25-107047.md) | [108 d](/filings/0001104659-26-014319.md) | [109](/filings/0001104659-26-051576.md) | [106](/filings/0001104659-26-088166.md) | [105](/filings/0001104659-25-107047.md) | [116 d](/filings/0001104659-26-014319.md) | [99.0](/filings/0001104659-26-051576.md) | [75.0](/filings/0001104659-26-088166.md) | | Operating income | $m | [82.0](/filings/0001558370-24-013964.md) | [(439) d](/filings/0001558370-25-000868.md) | [117](/filings/0001558370-25-006008.md) | [104](/filings/0001558370-25-009803.md) | [(57.0)](/filings/0001104659-25-107047.md) | [(125) d](/filings/0001558370-25-000868.md) | [18.0](/filings/0001104659-26-051576.md) | [7.0](/filings/0001104659-26-088166.md) | [58.0](/filings/0001104659-25-107047.md) | not reported | [(53.0)](/filings/0001104659-26-051576.md) | [(827)](/filings/0001104659-26-088166.md) | | Interest expense | $m | [78.0](/filings/0001558370-24-013964.md) | [79.0 d](/filings/0001104659-26-014319.md) | [78.0](/filings/0001558370-25-006008.md) | [87.0](/filings/0001558370-25-009803.md) | [87.0](/filings/0001104659-25-107047.md) | [83.0 d](/filings/0001104659-26-014319.md) | [81.0](/filings/0001104659-26-051576.md) | [85.0](/filings/0001104659-26-088166.md) | [91.0](/filings/0001104659-25-107047.md) | [84.0 d](/filings/0001104659-26-014319.md) | [79.0](/filings/0001104659-26-051576.md) | [86.0](/filings/0001104659-26-088166.md) | | Income tax | $m | [26.0](/filings/0001558370-24-013964.md) | [25.0 d](/filings/0001104659-26-014319.md) | [41.0](/filings/0001558370-25-006008.md) | [42.0](/filings/0001558370-25-009803.md) | [19.0](/filings/0001104659-25-107047.md) | [24.0 d](/filings/0001104659-26-014319.md) | [30.0](/filings/0001104659-26-051576.md) | [6.0](/filings/0001104659-26-088166.md) | [21.0](/filings/0001104659-25-107047.md) | [(3.0) d](/filings/0001104659-26-014319.md) | [18.0](/filings/0001104659-26-051576.md) | [138](/filings/0001104659-26-088166.md) | | Net income | $m | [51.0](/filings/0001558370-24-013964.md) | [(470) d](/filings/0001104659-26-014319.md) | [72.0](/filings/0001558370-25-006008.md) | [57.0](/filings/0001558370-25-009803.md) | [(80.0)](/filings/0001104659-25-107047.md) | [(154) d](/filings/0001104659-26-014319.md) | [(16.0)](/filings/0001104659-26-051576.md) | [(5.0)](/filings/0001104659-26-088166.md) | [30.0](/filings/0001104659-25-107047.md) | [(138) d](/filings/0001104659-26-014319.md) | [(73.0)](/filings/0001104659-26-051576.md) | [(972)](/filings/0001104659-26-088166.md) | | Diluted EPS | $ per share | [0.32](/filings/0001558370-24-013964.md) | not reported | [0.45](/filings/0001558370-25-006008.md) | [0.36](/filings/0001558370-25-009803.md) | [(0.52)](/filings/0001104659-25-107047.md) | not reported | [(0.10)](/filings/0001104659-26-051576.md) | [(0.03)](/filings/0001104659-26-088166.md) | [0.19](/filings/0001104659-25-107047.md) | not reported | [(0.48)](/filings/0001104659-26-051576.md) | [(6.33)](/filings/0001104659-26-088166.md) | | Basic EPS | $ per share | [0.33](/filings/0001558370-24-013964.md) | not reported | [0.46](/filings/0001558370-25-006008.md) | [0.37](/filings/0001558370-25-009803.md) | [(0.52)](/filings/0001104659-25-107047.md) | not reported | [(0.10)](/filings/0001104659-26-051576.md) | [(0.03)](/filings/0001104659-26-088166.md) | [0.19](/filings/0001104659-25-107047.md) | not reported | [(0.48)](/filings/0001104659-26-051576.md) | [(6.33)](/filings/0001104659-26-088166.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, us-gaap:Revenues - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [792](/filings/0001558370-24-013964.md) | [913](/filings/0001558370-25-000868.md) | [395](/filings/0001558370-25-006008.md) | [671](/filings/0001558370-25-009803.md) | [755](/filings/0001104659-25-107047.md) | [734](/filings/0001104659-26-014319.md) | [424](/filings/0001104659-26-051576.md) | [487](/filings/0001104659-26-088166.md) | [556](/filings/0001104659-25-107047.md) | [759](/filings/0001104659-26-088166.md) | [317](/filings/0001104659-26-051576.md) | [339](/filings/0001104659-26-088166.md) | | Current assets | $m | [2,899](/filings/0001558370-24-013964.md) | [2,884](/filings/0001558370-25-000868.md) | [2,660](/filings/0001558370-25-006008.md) | [2,819](/filings/0001558370-25-009803.md) | [2,822](/filings/0001104659-25-107047.md) | [2,478](/filings/0001104659-26-014319.md) | [2,391](/filings/0001104659-26-051576.md) | [2,604](/filings/0001104659-26-088166.md) | [2,660](/filings/0001104659-25-107047.md) | [2,601](/filings/0001104659-26-088166.md) | [2,384](/filings/0001104659-26-051576.md) | [2,451](/filings/0001104659-26-088166.md) | | Total assets | $m | [9,735](/filings/0001558370-24-013964.md) | [9,669](/filings/0001104659-26-014319.md) | [9,409](/filings/0001558370-25-006008.md) | [9,334](/filings/0001558370-25-009803.md) | [9,372](/filings/0001104659-25-107047.md) | [8,654](/filings/0001104659-26-014319.md) | [8,729](/filings/0001104659-26-051576.md) | [9,179](/filings/0001104659-26-088166.md) | [9,258](/filings/0001104659-25-107047.md) | [9,243](/filings/0001104659-26-088166.md) | [8,950](/filings/0001104659-26-051576.md) | [8,088](/filings/0001104659-26-088166.md) | | Current liabilities | $m | [2,070](/filings/0001558370-24-013964.md) | [2,346](/filings/0001558370-25-000868.md) | [2,602](/filings/0001558370-25-006008.md) | [2,234](/filings/0001558370-25-009803.md) | [2,292](/filings/0001104659-25-107047.md) | [2,160](/filings/0001104659-26-014319.md) | [1,931](/filings/0001104659-26-051576.md) | [2,102](/filings/0001104659-26-088166.md) | [1,993](/filings/0001104659-25-107047.md) | [2,089](/filings/0001104659-26-088166.md) | [1,894](/filings/0001104659-26-051576.md) | [1,944](/filings/0001104659-26-088166.md) | | Long-term debt | $m | [4,754](/filings/0001558370-24-013964.md) | [4,698](/filings/0001558370-25-000868.md) | [4,119](/filings/0001558370-25-006008.md) | [4,648](/filings/0001558370-25-009803.md) | [4,709](/filings/0001104659-25-107047.md) | [4,553](/filings/0001104659-26-014319.md) | [4,786](/filings/0001104659-26-051576.md) | [4,898](/filings/0001104659-26-088166.md) | [4,946](/filings/0001104659-25-107047.md) | [4,837](/filings/0001104659-26-088166.md) | [4,800](/filings/0001104659-26-051576.md) | [4,793](/filings/0001104659-26-088166.md) | | Current portion of debt | $m | [53.0](/filings/0001558370-24-013964.md) | [142](/filings/0001558370-25-000868.md) | [696](/filings/0001558370-25-006008.md) | [347](/filings/0001558370-25-009803.md) | [359](/filings/0001104659-25-107047.md) | [306](/filings/0001104659-26-014319.md) | [103](/filings/0001104659-26-051576.md) | [105](/filings/0001104659-26-088166.md) | [38.0](/filings/0001104659-25-107047.md) | [66.0](/filings/0001104659-26-088166.md) | [64.0](/filings/0001104659-26-051576.md) | [63.0](/filings/0001104659-26-088166.md) | | Short-term borrowings | $m | not reported | [106](/filings/0001558370-25-000868.md) | not reported | not reported | not reported | [110](/filings/0001104659-26-014319.md) | not reported | not reported | not reported | [96.0](/filings/0001104659-26-014319.md) | not reported | not reported | | Shareholders' equity | $m | [2,113](/filings/0001558370-24-013964.md) | [1,609](/filings/0001558370-25-000868.md) | [1,826](/filings/0001558370-25-009803.md) | [1,631](/filings/0001104659-25-107047.md) | [1,481](/filings/0001104659-25-107047.md) | [1,079](/filings/0001104659-26-014319.md) | [1,249](/filings/0001104659-26-088166.md) | [1,369](/filings/0001104659-26-088166.md) | [1,470](/filings/0001104659-25-107047.md) | [1,294](/filings/0001104659-26-014319.md) | [1,432](/filings/0001104659-26-088166.md) | [539](/filings/0001104659-26-088166.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Short-term borrowings: us-gaap:ShortTermBorrowings - Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [339 d](/filings/0001558370-24-013964.md) | [381 d](/filings/0001104659-26-014319.md) | [(270)](/filings/0001558370-25-006008.md) | [250 d](/filings/0001558370-25-009803.md) | [191 d](/filings/0001104659-25-107047.md) | [318 d](/filings/0001104659-26-014319.md) | [(171)](/filings/0001104659-26-051576.md) | [155 d](/filings/0001104659-26-088166.md) | [214 d](/filings/0001104659-25-107047.md) | [402 d](/filings/0001104659-26-014319.md) | [(294)](/filings/0001104659-26-051576.md) | [94.0 d](/filings/0001104659-26-088166.md) | | Capital expenditure | $m | [197 d](/filings/0001558370-24-013964.md) | [223 d](/filings/0001104659-26-014319.md) | [213](/filings/0001558370-25-006008.md) | [160 d](/filings/0001558370-25-009803.md) | [136 d](/filings/0001104659-25-107047.md) | [108 d](/filings/0001104659-26-014319.md) | [135](/filings/0001104659-26-051576.md) | [104 d](/filings/0001104659-26-088166.md) | [100 d](/filings/0001104659-25-107047.md) | [93.0 d](/filings/0001104659-26-014319.md) | [142](/filings/0001104659-26-051576.md) | [95.0 d](/filings/0001104659-26-088166.md) | | Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Share repurchases | $m | [10.0 d](/filings/0001558370-24-013964.md) | [10.0 d](/filings/0001104659-26-014319.md) | [10.0](/filings/0001558370-25-006008.md) | [10.0 d](/filings/0001558370-25-009803.md) | [10.0 d](/filings/0001104659-25-107047.md) | [10.0 d](/filings/0001104659-26-014319.md) | [10.0](/filings/0001104659-26-051576.md) | [10.0 d](/filings/0001104659-26-088166.md) | [10.0 d](/filings/0001104659-25-107047.md) | [10.0 d](/filings/0001104659-26-014319.md) | [10.0](/filings/0001104659-26-051576.md) | [0.0 d](/filings/0001104659-26-088166.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: not reported - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [159](/filings/0001558370-23-017248.md) | [159](/filings/0001558370-24-006397.md) | [159](/filings/0001558370-24-010487.md) | [159](/filings/0001558370-24-013964.md) | [158](/filings/0001558370-25-006008.md) | [157](/filings/0001558370-25-009803.md) | [155](/filings/0001104659-25-107047.md) | [154](/filings/0001104659-26-051576.md) | [154](/filings/0001104659-26-088166.md) | [155](/filings/0001104659-25-107047.md) | [153](/filings/0001104659-26-051576.md) | [153](/filings/0001104659-26-088166.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 153,659,747 at 2026-06-30, from the cover of the [10-Q filed 2026-07-29](/filings/0001104659-26-088166.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.